NEW ACTIVE PHARMACEUTICAL INGREDIENTS FUNDAMENTALS EXPLAINED

“The existing circumstance has exposed some structural weaknesses in the EU’s medicines supply chain as well as a large dependence on non-EU countries for active pharmaceutical ingredients,” Kyriakides claimed. She encouraged that provide chain challenges be resolved in an EU pharmaceutical technique expected for being released by the end in